149 related articles for article (PubMed ID: 22270451)
21. [Correlation between matrix metalloproteinases-2 and tissue inhibitor of metalloproteinase-2 expression, metastatic potential and tumor angiogenesis in synovial sarcoma and its prognostic significance].
Sun BC; Sun Y; Zhao XL; Wang J; Wang X; Liu YX
Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):155-8. PubMed ID: 16630504
[TBL] [Abstract][Full Text] [Related]
22. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer.
Tunuguntla R; Ripley D; Sang QX; Chegini N
Gynecol Oncol; 2003 Jun; 89(3):453-9. PubMed ID: 12798711
[TBL] [Abstract][Full Text] [Related]
23. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
24. Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients' survival in breast cancer.
Nakopoulou L; Katsarou S; Giannopoulou I; Alexandrou P; Tsirmpa I; Panayotopoulou E; Mavrommatis J; Keramopoulos A
Mod Pathol; 2002 Jan; 15(1):26-34. PubMed ID: 11796838
[TBL] [Abstract][Full Text] [Related]
25. High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma.
Honkavuori M; Talvensaari-Mattila A; Puistola U; Turpeenniemi-Hujanen T; Santala M
Anticancer Res; 2008; 28(5A):2715-9. PubMed ID: 19035300
[TBL] [Abstract][Full Text] [Related]
26. Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study.
Graesslin O; Cortez A; Fauvet R; Lorenzato M; Birembaut P; Daraï E
Ann Oncol; 2006 Apr; 17(4):637-45. PubMed ID: 16407419
[TBL] [Abstract][Full Text] [Related]
27. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221
[TBL] [Abstract][Full Text] [Related]
28. [Activity of matrix metalloproteinases -2 and -9 (MMP-2 and MMP-9) and content of their tissue inhibitors in endometrial cancer--a preliminary study].
Bogusiewicz M; Stryjecka-Zimmer M; Rechberger T
Ginekol Pol; 2007 May; 78(5):366-72. PubMed ID: 17867327
[TBL] [Abstract][Full Text] [Related]
29. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
30. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S
Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
[TBL] [Abstract][Full Text] [Related]
31. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
[TBL] [Abstract][Full Text] [Related]
32. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
33. Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer.
Steffensen KD; Waldstrøm M; Christensen RK; Bartels A; Brünner N; Jakobsen A
BMC Cancer; 2010 May; 10():185. PubMed ID: 20459644
[TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
35. CyclinD1, a prominent prognostic marker for endometrial diseases.
Liang S; Mu K; Wang Y; Zhou Z; Zhang J; Sheng Y; Zhang T
Diagn Pathol; 2013 Aug; 8():138. PubMed ID: 23947899
[TBL] [Abstract][Full Text] [Related]
36. Loss of TIMP-1 immune expression and tumor recurrence in localized prostate cancer.
Reis ST; Viana NI; Iscaife A; Pontes-Junior J; Dip N; Antunes AA; Guimarães VR; Santana I; Nahas WC; Srougi M; Leite KR
Int Braz J Urol; 2015; 41(6):1088-95. PubMed ID: 26742965
[TBL] [Abstract][Full Text] [Related]
37. Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data.
Alkushi A; Clarke BA; Akbari M; Makretsov N; Lim P; Miller D; Magliocco A; Coldman A; van de Rijn M; Huntsman D; Parker R; Gilks CB
Mod Pathol; 2007 Nov; 20(11):1156-65. PubMed ID: 17717550
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of MMSET in endometrial cancer: a clinicopathologic study.
Xiao M; Yang S; Chen J; Ning X; Guo L; Huang K; Sui L
J Surg Oncol; 2013 Mar; 107(4):428-32. PubMed ID: 22886632
[TBL] [Abstract][Full Text] [Related]
39. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ
J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622
[TBL] [Abstract][Full Text] [Related]
40. Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Am J Clin Pathol; 2000 Sep; 114(3):402-11. PubMed ID: 10989641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]